Award details

Translational control by non-coding RNA in Marek's disease herpesvirus: implications in oncogenesis and exploitation in bioengineering

ReferenceBBS/E/I/00001483
Principal Investigator / Supervisor Professor Venugopal Nair
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 127,762
StatusCompleted
TypeInstitute Project
Start date 01/04/2010
End date 31/03/2013
Duration36 months

Abstract

Studies of virus-infected cells have been a prominent source of information on the mechanism of translational control. Because viruses are obligate intracellular parasites, they depend on cells for their replication. Nowhere is this dependency seen more clearly than in the translation system, as viruses lack a translational apparatus. Consequently, viruses must use the cellular apparatus for the synthesis of viral proteins. Many viruses have evolved ways to gain a translational advantage for their mRNAs. This is particularly crucial during the very early stages of viral infection where immediate-early transcripts are produced and need to be translated. Internal ribosome entry site (IRES)-mediated translation initiation is one of the strategies that viruses use during time of cellular stress and when cap-dependent translation might be inhibited. We have discovered that the protein translation from one of the immediate-early transcripts of MDV (named 1.8kBtranscript) is controlled using two IRES elements and the translational strategy used by MDV in the causation of disease will be the subject of investigation under this project.

Summary

unavailable
Committee Not funded via Committee
Research TopicsAnimal Health, Microbiology
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file